Kubra KARAGOZ

Kubra KARAGOZ

Rutgers, The State University of New Jersey

H-index: 14

North America-United States

About Kubra KARAGOZ

Kubra KARAGOZ, With an exceptional h-index of 14 and a recent h-index of 13 (since 2020), a distinguished researcher at Rutgers, The State University of New Jersey, specializes in the field of Cancer genomics, Transcriptomics, Proteomics, Systems Biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Molecular stratification of AML: Integrative genomic and immune profiling points to high risk subgroup and targetable molecular drivers

Unbiased Subtyping of AML: Unraveling Genomic and Transcriptomic Features for Precision Medicine and Targeted Therapies Using Beat-AML and TCGA Data

Improving accuracy of gpt-3/4 results on biomedical data using a retrieval-augmented language model

Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma

QOPI Clinical Informatics: A digital platform to enable real-time quality reporting, clinical decision support, and rapid learning.

Analysis of genomic alterations and treatment landscape in patients with advanced tumors using real-world data for precision oncology.

Multiple myeloma patient tumors with high levels of cereblon exon-10 deletion splice variant upregulate clinically targetable pro-inflammatory cytokine pathways

Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma

Kubra KARAGOZ Information

University

Position

Postdoctoral Research Fellow at Rutgers Cancer Institute of New Jersey

Citations(all)

771

Citations(since 2020)

638

Cited By

399

hIndex(all)

14

hIndex(since 2020)

13

i10Index(all)

15

i10Index(since 2020)

14

Email

University Profile Page

Rutgers, The State University of New Jersey

Google Scholar

View Google Scholar Profile

Kubra KARAGOZ Skills & Research Interests

Cancer genomics

Transcriptomics

Proteomics

Systems Biology

Top articles of Kubra KARAGOZ

Title

Journal

Author(s)

Publication Date

Molecular stratification of AML: Integrative genomic and immune profiling points to high risk subgroup and targetable molecular drivers

Cancer Research

Kubra Karagoz

Lauren Brady

Brandon Higgs

Han Si

2024/3/22

Unbiased Subtyping of AML: Unraveling Genomic and Transcriptomic Features for Precision Medicine and Targeted Therapies Using Beat-AML and TCGA Data

Blood

Kubra Karagoz

Lauren K Brady

Brandon Higgs

Han Si

2023/11/28

Improving accuracy of gpt-3/4 results on biomedical data using a retrieval-augmented language model

arXiv preprint arXiv:2305.17116

David Soong

Sriram Sridhar

Han Si

Jan-Samuel Wagner

Ana Caroline Costa Sá

...

2023/5/26

Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma

Blood cancer journal

Keiji Kurata

Anna James-Bott

Mark A Tye

Leona Yamamoto

Mehmet K Samur

...

2023/1/12

QOPI Clinical Informatics: A digital platform to enable real-time quality reporting, clinical decision support, and rapid learning.

Casey B Williams

Kubra Karagoz

Rachel Elsey

Tobias Meißner

Mitchell Higashi

...

2022/6/1

Analysis of genomic alterations and treatment landscape in patients with advanced tumors using real-world data for precision oncology.

Kubra Karagoz

Kristin Ayers

Bonny Patel

Jason D Wells

Scott Newman

...

2022/6/1

Multiple myeloma patient tumors with high levels of cereblon exon-10 deletion splice variant upregulate clinically targetable pro-inflammatory cytokine pathways

Frontiers in Genetics

Kubra Karagoz

Matthew Stokes

María Ortiz-Estévez

Fadi Towfic

Erin Flynt

...

2022/2/9

Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma

Blood, The Journal of the American Society of Hematology

Sarah Gooding

Naser Ansari-Pour

Mohammad Kazeroun

Kubra Karagoz

Ann Polonskaia

...

2022/10/20

Loss of COP9 signalosome gene-containing 2q region is associated with lenalidomide and pomalidomide resistance in myeloma patients

Blood

Sarah Gooding

Naser Ansari-Pour

Mohammad H Kazeroun

Kubra Karagoz

Mirian Angulo Salazar

...

2021/11/23

Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’[EBioMedicine 38 (2018) 100–112]

EBioMedicine

Pinar Kanlikilicer

Recep Bayraktar

Merve Denizli

Mohammed H Rashed

Cristina Ivan

...

2020/2/1

Aggressive mammary cancers lacking lymphocytic infiltration arise in irradiated mice and can be prevented by dietary intervention

Cancer immunology research

Coral Omene

Lin Ma

Jade Moore

Haoxu Ouyang

Irineu Illa-Bochaca

...

2020/2/1

See List of Professors in Kubra KARAGOZ University(Rutgers, The State University of New Jersey)

Co-Authors

H-index: 31
Kazim Yalcin Arga

Kazim Yalcin Arga

Marmara Üniversitesi

H-index: 18
Beste Calimlioglu Turanli

Beste Calimlioglu Turanli

Marmara Üniversitesi

academic-engine